Skip to main content
. 2021 Feb 26;11:4804. doi: 10.1038/s41598-021-84439-8

Table 2.

Study parameters upon stratification by eosinophil count.

Parameter Eosinopenia
n = 99 (36%)
Normal eosinophil count
n = 176 (64%)
P-value
Age (years), mean (SD) 70.24 (9.48) 68.96 (9.64) 0.29
Male, n (%) 51 (51.51) 101 (57.39) 0.42
Active smoker, n (%) 58 (58.59) 44 (25) < 0.0001
Length of hospitalizationc (days), median (IQR) 8 (6–12.75) 7 (5–10) 0.004
Character of ECOPD
Infectious, n (%) 60 (60.61) 86 (48.86) 0.06
CRP (mg/l), median (IQR) 15.53 (6.79–30.29) 10.14 (2.79–23.41) 0.07
WBC (× 103/μl), median (IQR) 11.4 (8.17–13.2) 8.9 (7.67–11.57) 0.0007
Lymphocytes (× 103/μl), median (IQR) 1.1 (0.7–1.8) 1.8 (1.2–2.4) < 0.0001
Neutrophils (× 103/μl), median (IQR) 9.2 (6.1–11.55) 6.1 (4.6–7.95) < 0.0001
NLR, median (IQR) 8.44 (4.37–12.72) 2.26 (0.14–3.69) < 0.0001
Hemoglobin (g/dl), median (IQR) 13.9 (12.6–15.15) 14.2 (13–15.13) 0.29
pH, median (IQR) 7.42 (7.39–7.46) 7.42 (7.39–7.45) 0.65
pCO2 (mmHg), median (IQR) 38.9 (35.2–47.65) 38.7 (35.3–44.5) 0.86
pO2 (mmHg), median (IQR) 63.9 (54.5–73.5) 63 (55.65–71) 0.96
SaO2 (%), median (IQR) 92.7 (88.05–95.3) 92.4 (89.65–94.8) 0.86
HCO3− (mEq/l), median (IQR) 26 (23.93–28.68) 24.95 (23.2–27.98) 0.1
BE (mEq/l), median (IQR) 1.5 (− 0.08 to 3.73) 0.75 (− 0.7 to 2.48) 0.04
Comorbidities
Ischemic heart disease, n (%) 37 (37.37) 49 (27.84) 0.1
AFa, n (%) 20 (20.2) 11 (6.25) 0.0004
Arrhythmia other than AFb, n (%) 2 (2.02) 6 (3.41) 0.72
Congestive heart failure, n (%) 45 (45.45) 71 (40.34) 0.41
Arterial hypertension, n (%) 57 (57.58) 122 (69.32) 0.05
Type 2 diabetes, n (%) 26 (26.26) 40 (22.73) 0.51
Others, n (%) 83 (83.84) 69 (39.2) 0.0003

AF atrial fibrillation, CRP c-reactive protein, IQR interquartile range, WBC white blood count.

aFirst detected in the admission, paroxysmal, persistent or permanent.

bIn the admission or in the past medical history.

cAmong survivors.